Cyclenium has programs in oncology, infectious diseases and inflammation/pain on its own or in partnership with academic and non-profit organizations as well as collaborations with pharmaceutical and biotechnology companies.
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze